Cargando…

A randomized, double-blind comparison of OROS(® )hydromorphone and controlled-release morphine for the control of chronic cancer pain

BACKGROUND: Long-acting opioid formulations are advocated for maintaining pain control in chronic cancer pain. OROS(® )hydromorphone is a sustained-release formulation of hydromorphone that requires dosing once daily to maintain therapeutic concentrations. The objective of this study was to demonstr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hanna, Magdi, Thipphawong, John
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2644667/ https://www.ncbi.nlm.nih.gov/pubmed/18976472 http://dx.doi.org/10.1186/1472-684X-7-17

Ejemplares similares

An open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS(® )hydromorphone in patients with chronic cancer pain
por: Hanna, Magdi, et al.
Publicado: (2009)

Pharmacokinetic profile of a 24-hour controlled-release OROS(® )formulation of hydromorphone in the presence and absence of food
por: Sathyan, Gayatri, et al.
Publicado: (2007)

Once-daily OROS® hydromorphone for the management of chronic nonmalignant pain: a dose-conversion and titration study
por: Wallace, M, et al.
Publicado: (2007)

A new extended release formulation (OROS(®)) of hydromorphone in the management of pain
por: Weinstein, Sharon M
Publicado: (2009)

Pharmacokinetic investigation of dose proportionality with a 24-hour controlled-release formulation of hydromorphone
por: Sathyan, Gayatri, et al.
Publicado: (2007)

Repeat-dose steady-state pharmacokinetic evaluation of once-daily hydromorphone extended-release (OROS(®) hydromorphone ER) in patients with chronic pain
por: Vandenbossche, Joris, et al.
Publicado: (2012)

A double-blind, randomized comparative study to investigate the morphine to hydromorphone conversion ratio in Japanese cancer patients
por: Inoue, Satoshi, et al.
Publicado: (2018)

Patient-controlled analgesia in the pediatric population: morphine versus hydromorphone
por: DiGiusto, Matthew, et al.
Publicado: (2014)

Within-subject, double-blind, randomized, placebo-controlled evaluation of combining the cannabinoid dronabinol and the opioid hydromorphone in adults with chronic pain
por: Campbell, Claudia M., et al.
Publicado: (2023)

The efficacy and safety of epidural morphine/hydromorphone in the treatment of intractable postherpetic neuralgia: A single-center, double-blinded, randomized controlled, prospective, and non-inferiority study
por: Yiping, Sun, et al.
Publicado: (2022)

A Phase IIIb, Multicentre, Randomised, Parallel-Group, Placebo-Controlled, Double-Blind Study to Investigate the Efficacy and Safety of OROS Hydromorphone in Subjects with Moderate-to-Severe Chronic Pain Induced by Osteoarthritis of the Hip or the Knee
por: Vojtaššák, Jozef, et al.
Publicado: (2011)

Hydromorphone/lorazepam/morphine overdose: Coma: case report
Publicado: (2019)

Effectiveness and gastrointestinal tolerability during conversion and titration with once-daily OROS® hydromorphone extended release in opioid-tolerant patients with chronic low back pain
por: Hale, Martin E, et al.
Publicado: (2013)

Effect of preoperative hydromorphone in patients undergoing laparoscopic radical gastrectomy: A double-blind, randomized and controlled trial
por: Wang, Jinguo, et al.
Publicado: (2018)

Morphine versus Hydromorphone: Does Choice of Opioid Influence Outcomes?
por: Gulur, Padma, et al.
Publicado: (2015)

Once-Daily OROS Hydromorphone for Management of Cancer Pain: an Open-Label, Multi-Center, Non-Interventional Study
por: Park, Cheol Kyu, et al.
Publicado: (2016)

Within-subject, double-blinded, randomized, and placebo-controlled evaluation of the combined effects of the cannabinoid dronabinol and the opioid hydromorphone in a human laboratory pain model
por: Dunn, Kelly E., et al.
Publicado: (2021)

Fulranumab in patients with interstitial cystitis/bladder pain syndrome: observations from a randomized, double-blind, placebo-controlled study
por: Wang, Hao, et al.
Publicado: (2017)

A randomized, double-blind study of hydromorphone hydrochloride extended-release tablets versus oxycodone hydrochloride extended-release tablets for cancer pain: efficacy and safety in Japanese cancer patients (EXHEAL: a Phase III study of EXtended-release HydromorphonE for cAncer pain reLief)
por: Inoue, Satoshi, et al.
Publicado: (2017)

Controlled-release hydromorphone and risk of infection in adults: a systematic review
por: Tricco, Andrea C., et al.
Publicado: (2023)

A randomized, double-blind, non-inferiority study of hydromorphone hydrochloride immediate-release tablets versus oxycodone hydrochloride immediate-release powder for cancer pain: efficacy and safety in Japanese cancer patients
por: Inoue, Satoshi, et al.
Publicado: (2018)

Stability evaluation of morphine, hydromorphone, metamizole and esketamine containing analgesic mixtures applied for patient‐controlled analgesia in hospice and palliative care
por: Harder, Matthias, et al.
Publicado: (2022)

Intravenous acetaminophen with morphine versus intravenous morphine alone for acute pain in the emergency room: protocol for a multicenter, randomized, placebo-controlled, double-blinded study (ADAMOPA)
por: Cattin, Guillaume, et al.
Publicado: (2022)

Morphine versus Nalbuphine for Open Gynaecological Surgery: A Randomized Controlled Double Blinded Trial
por: Akshat, Shiv, et al.
Publicado: (2014)

Comparison of Intravenous Ketamine with Morphine in Pain Relief of Long Bones Fractures: a Double Blind Randomized Clinical Trial
por: Majidinejad, Saeed, et al.
Publicado: (2014)

Satisfactory Analgesia with Minimal Emesis in Day Surgeries (SAME DayS): a protocol for a randomised controlled trial of morphine versus hydromorphone
por: Shanthanna, Harsha, et al.
Publicado: (2018)

Randomised, double-blind controlled trial by dose reduction of implanted intrathecal morphine delivery in chronic non-cancer pain
por: Raphael, Jon H, et al.
Publicado: (2013)

Comparison of Clinical Efficacy of Intravenous Acetaminophen with Intravenous Morphine in Acute Renal Colic: A Randomized, Double-Blind, Controlled Trial
por: Masoumi, Kambiz, et al.
Publicado: (2014)

Fulranumab in Patients With Pain Associated With Postherpetic Neuralgia and Postraumatic Neuropathy: Efficacy, Safety, and Tolerability Results From a Randomized, Double-blind, Placebo-controlled, Phase-2 Study
por: Wang, Hao, et al.
Publicado: (2017)

Clinical Usefulness of Hydromorphone-OROS in Improving Sleep Disturbances in Korean Cancer Patients: A Multicenter, Prospective, Open-Label Study
por: Shin, Seong Hoon, et al.
Publicado: (2014)

A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients
por: Nosek, Krzysztof, et al.
Publicado: (2017)

Hydromorphone vs sufentanil in patient-controlled analgesia for postoperative pain management: A meta-analysis
por: Nie, Zhong-Biao, et al.
Publicado: (2022)

Complementary pharmacokinetic measures to further define the profile of once-daily OROS hydromorphone ER during single-dose and steady-state dosing
por: Devarakonda, Krishna, et al.
Publicado: (2013)

Stability of Fentanyl Citrate, Hydromorphone Hydrochloride, Ketamine Hydrochloride, Midazolam, Morphine Sulfate, and Pentobarbital Sodium in Polypropylene Syringes
por: Anderson, Collin, et al.
Publicado: (2015)

Recrudescence of Focal Stroke Symptoms during Pain Management with Hydromorphone
por: Bernstock, Joshua D., et al.
Publicado: (2016)

Hydromorphone Prescription for Pain in Children—What Place in Clinical Practice?
por: Rodieux, Frédérique, et al.
Publicado: (2022)

Randomized double blind trial of intraperitoneal instillation of bupivacaine and morphine for pain relief after laparoscopic gynecological surgeries
por: Butala, Bina P., et al.
Publicado: (2013)

Intravenous acetaminophen does not reduce morphine use for pain relief in emergency department patients: A multicenter, randomized, double‐blind, placebo‐controlled trial
por: Minotti, Bruno, et al.
Publicado: (2022)

A prospective multicentre study to evaluate the efficacy and tolerability of osmotic release oral system (OROS(®)) hydromorphone in opioid-naive cancer patients: Results of the Korean South West Oncology Group study
por: Song, Eun-Kee, et al.
Publicado: (2015)

Effectiveness of analgesia with hydromorphone hydrochloride for postoperative pain following surgical repair of structural congenital malformations in children: a randomized controlled trial
por: Pan, Yongying, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5jcnkbgbbc0cgqev49l0ivmlh2